The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForterra Regulatory News (FORT)

Share Price Information for Forterra (FORT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 168.00
Bid: 167.80
Ask: 168.00
Change: 0.00 (0.00%)
Spread: 0.20 (0.119%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 168.00
FORT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of Bison Manufacturing Ltd

28 Jul 2017 07:00

RNS Number : 3528M
Forterra plc
28 July 2017
 

28 July 2017

 

Forterra plc

Acquisition of the trade and assets of Bison Manufacturing Ltd

 

Forterra plc ("Forterra"), a leading UK producer of manufactured masonry products, announces that it has entered into an agreement to acquire the trade and assets of Bison Manufacturing Ltd ("Bison") from Laing O'Rourke plc ("Laing O'Rourke") for £20m. The acquisition will be funded from the Group's existing cash balances and is expected to complete in Q3 2017. Bison is the UK market leading manufacturer of hollowcore precast concrete flooring with a highly automated manufacturing facility located at Swadlincote, Derbyshire, which was opened in 2006.

 

This acquisition provides a unique and immediate opportunity for Forterra to take a leadership position in the UK precast concrete market whilst also expanding its currently capacity-constrained business. It also enables the Group to take advantage of the growing demand for these products in the residential, commercial and infrastructure markets, which are underpinned by Government initiatives to tackle the country's housing deficit and improve infrastructure. The Swadlincote plant is the largest and most technically advanced hollowcore manufacturing facility in the UK. In addition, the site includes a specialist precast facility capable of producing a wide range of bespoke precast concrete products. Forterra management estimate that it would cost in excess of £35m to replicate these assets on a greenfield site. Furthermore, the Bison brand is highly respected and valued in the precast market.

 

The Swadlincote plant has been operating at little more than 50% capacity utilisation. The acquisition will allow Forterra to expand its own precast concrete business to enable increased sales across our range of concrete product whilst benefiting from production efficiencies and economies of scale as the utilisation of the Swadlincote facility is substantially increased.

 

The acquisition also provides an opportunity to partner with Laing O'Rourke, a leading innovator and pioneer in off-site construction methods, and includes a five year commercial agreement for Forterra to supply hollowcore and other precast products to Laing O'Rourke.

 

The acquisition constitutes a Class 2 transaction for the purposes of the UK Financial Conduct Authority's Listing Rules. The gross assets that are subject to the transaction relate purely to tangible fixed assets and inventory at the Swadlincote site and had a net book value in the financial statements of the seller of £10.0 million at 31 March 2017. Revenue attributable to those assets was £22.8 million for the year to 31 March 2017, and the loss (at EBITDA level) attributable to those assets was £1.1 million.

 

Following completion, Forterra expects to generate a return on its investment in excess of its cost of capital by 2019 through efficiency improvements, proposed consolidation of production between sites and leveraging procurement synergies.

 

Stephen Harrison, Chief Executive, commented:

 

"The acquisition is a unique opportunity to transform Forterra's precast business in terms of scale and capability. We are acquiring well invested assets whilst at the same time solving the capacity constraints on growth within our own business. We gain a well-respected brand and will attain a market leading position as we look to grow the combined business.

 

"We are confident that the acquisition will create value for our shareholders".

 

Forterra will announce half year results for the six months ended 30 June 2017 on 1 August 2017.

 

 

Enquiries

Forterra plc:

+44 (0) 1604 707 600

Stephen Harrison (CEO)

Shatish Dasani (CFO)

FTI Consulting:

+44 (0) 20 3727 1340

Richard Mountain

Nick Hasell

 

Further information relating to the Company and its group can be found at www.forterraplc.co.uk

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQRRMATMBITBLR
Date   Source Headline
15th Jun 20219:56 amRNSDirector/PDMR Shareholding
7th Jun 20219:24 amRNSEmployee Benefit Trust Share Purchase
27th May 20213:45 pmRNSDirector/PDMR Shareholding
18th May 20213:45 pmRNSAnnual General Meeting 2021 Results
18th May 202110:28 amRNSProgressive publishes new research
18th May 20217:00 amRNSTrading Statement
6th May 20217:00 amRNSEmployee Benefit Trust Share Purchase
30th Apr 20214:07 pmRNSHolding(s) in Company
30th Apr 20211:11 pmRNSGrant under Performance Share Plan
9th Apr 20213:46 pmRNSDirector/PDMR Shareholding
9th Apr 202110:56 amRNSHolding(s) in Company
9th Apr 20217:00 amRNSAnnual Report 2020 and Notice of AGM 2021
8th Apr 20213:31 pmRNSEmployee Benefit Trust Share Purchase
1st Apr 202110:59 amRNSDirector/PDMR Shareholding
30th Mar 20211:14 pmRNSDirector/PDMR Shareholding
25th Mar 20212:41 pmRNSDirector/PDMR Shareholding
22nd Mar 20213:55 pmRNSDirector/PDMR Shareholding
11th Mar 20217:00 amRNSDirector/PDMR Shareholding
9th Mar 20217:00 amRNS2020 FULL YEAR RESULTS
4th Mar 20217:24 amRNSHolding(s) in Company
3rd Mar 202110:36 amRNSHolding(s) in Company
2nd Mar 20217:00 amRNSEmployee Benefit Trust Share Purchase
17th Feb 20213:16 pmRNSHolding(s) in Company
15th Feb 20217:00 amRNSDirector/PDMR Shareholding
8th Feb 20212:16 pmRNSDirector/PDMR Shareholding
2nd Feb 20214:17 pmRNSEmployee Benefit Trust Share Purchase
1st Feb 20214:48 pmRNSDirector/PDMR Shareholding
28th Jan 202112:38 pmRNSHolding(s) in Company
27th Jan 20213:40 pmRNSHolding(s) in Company
26th Jan 20218:15 amRNSProgressive publishes new research
26th Jan 20217:00 amRNSTrading Statement
6th Jan 20217:21 amRNSEmployee Benefit Trust Share Purchase
6th Jan 20217:21 amRNSDirector/PDMR Shareholding
4th Jan 20219:29 amRNSHolding(s) in Company
8th Dec 20202:28 pmRNSEmployee Benefit Trust Share Purchase
27th Nov 20207:00 amRNSEmployee Benefit Trust Share Purchase
24th Nov 20201:00 pmRNSEmployee Benefit Trust Share Purchase
24th Nov 20208:24 amRNSProgressive publishes new research
24th Nov 20207:00 amRNSTrading Statement
5th Nov 20205:09 pmRNSHolding(s) in Company
9th Oct 20203:45 pmRNSGrant of Options under 2020 SAYE Scheme
18th Sep 202010:12 amRNSGrant under Performance Share Plan
18th Sep 20209:40 amRNSHolding(s) in Company
14th Sep 20201:50 pmRNSProgressive publishes new research
14th Sep 20209:05 amRNSHolding(s) in Company
10th Sep 20207:00 amRNS2020 HALF YEAR RESULTS
7th Sep 20205:34 pmRNSHolding(s) in Company
14th Aug 20201:45 pmRNSHolding(s) in Company
30th Jul 20204:54 pmRNSHolding(s) in Company
16th Jul 202010:09 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.